title: HLA-B*1502 screening and toxic effects of carbamazepine.
authors.forename: Wei-Ping
authors.initials: WP
authors.lastname: Liao
authors.forename: Yi-Wu
authors.initials: YW
authors.lastname: Shi
authors.forename: Fu-Li
authors.initials: FL
authors.lastname: Min
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D044466:Asian People / Q000235:genetics; D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D064420:Drug-Related Side Effects and Adverse Reactions / Q000235:genetics*; D005838:Genotype; D015235:HLA-B Antigens / Q000235:genetics*; D059910:HLA-B15 Antigen; D006801:Humans; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D044465:White People / Q000235:genetics
chemical_list: D000927:Anticonvulsants; D015235:HLA-B Antigens; C483536:HLA-B*15:02 antigen; D059910:HLA-B15 Antigen; D002220:Carbamazepine